Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Kosiborod MN, Jhund PS, Docherty KF, Diez M, Petrie MC, Verma S, Nicolau JC, Merkely B, Kitakaze M, DeMets DL, Inzucchi SE, Køber L, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, Bengtsson O, Lindholm D, Niklasson A, Sjöstrand M, Langkilde AM, McMurray JJV. Kosiborod MN, et al. Among authors: kitakaze m. Circulation. 2020 Jan 14;141(2):90-99. doi: 10.1161/CIRCULATIONAHA.119.044138. Epub 2019 Nov 17. Circulation. 2020. PMID: 31736335 Free PMC article. Clinical Trial.
Bidirectional effects of aminophylline on myocardial ischemia.
Minamino T, Kitakaze M, Morioka T, Node K, Shinozaki Y, Chujo M, Mori H, Takeda H, Inoue M, Hori M, et al. Minamino T, et al. Among authors: kitakaze m. Circulation. 1995 Sep 1;92(5):1254-60. doi: 10.1161/01.cir.92.5.1254. Circulation. 1995. PMID: 7648673
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Sanada S, Kitakaze M, Papst PJ, Asanuma H, Node K, Takashima S, Asakura M, Ogita H, Liao Y, Sakata Y, Ogai A, Fukushima T, Yamada J, Shinozaki Y, Kuzuya T, Mori H, Terada N, Hori M. Sanada S, et al. Among authors: kitakaze m. Circulation. 2001 Aug 7;104(6):705-10. doi: 10.1161/hc3201.092216. Circulation. 2001. PMID: 11489779
Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Yasumura Y, Miyatake K, Okamoto H, Miyauchi T, Kawana M, Tsutamoto T, Kitakaze M, Matsubara H, Takaoka H, Anzai T, Himeno H, Yokoyama H, Yokoya K, Shintani U, Hashimoto K, Koretsune Y, Nakamura Y, Imai K, Maruyama S, Masaoka Y, Sekiya M, Shiraki T, Shinohara H, Ozono K, Matsuoka T, Miyao Y, Nomura F. Yasumura Y, et al. Among authors: kitakaze m. Circ J. 2004 Apr;68(4):361-6. doi: 10.1253/circj.68.361. Circ J. 2004. PMID: 15056835 Free article. Clinical Trial.
604 results